(0.34%) 5 117.14 points
(0.32%) 38 362 points
(0.38%) 15 988 points
(-0.88%) $83.11
(5.93%) $2.04
(0.40%) $2 356.70
(0.42%) $27.65
(3.87%) $957.75
(-0.22%) $0.933
(-0.40%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
@ $3.53
発行日: 14 2月 2024 @ 06:00
リターン: -30.45%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: -2.22 %
Live Chart Being Loaded With Signals
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States...
Stats | |
---|---|
本日の出来高 | 303 563 |
平均出来高 | 844 146 |
時価総額 | 323.97M |
EPS | $0 ( 2024-02-29 ) |
次の収益日 | ( $-0.0300 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 61.38 |
ATR14 | $0.00500 (0.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Bilbo Patrick | Sell | 2 497 | Class A Common Stock |
2024-04-01 | Freedman Lori | Sell | 1 974 | Class A Common Stock |
2024-04-01 | Grow Brian | Sell | 1 977 | Class A Common Stock |
2024-04-01 | Montecalvo Antonio S. | Sell | 1 752 | Class A Common Stock |
2024-04-01 | Gillheeney Gary S. | Sell | 10 113 | Class A Common Stock |
INSIDER POWER |
---|
76.84 |
Last 100 transactions |
Buy: 10 573 799 | Sell: 1 753 267 |
ボリューム 相関
Organogenesis Holdings 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Organogenesis Holdings 相関 - 通貨/商品
Organogenesis Holdings 財務諸表
Annual | 2023 |
収益: | $433.14M |
総利益: | $309.79M (71.52 %) |
EPS: | $0.0377 |
FY | 2023 |
収益: | $433.14M |
総利益: | $309.79M (71.52 %) |
EPS: | $0.0377 |
FY | 2022 |
収益: | $450.89M |
総利益: | $345.87M (76.71 %) |
EPS: | $0.120 |
FY | 2021 |
収益: | $468.06M |
総利益: | $353.86M (75.60 %) |
EPS: | $0.740 |
Financial Reports:
No articles found.
Organogenesis Holdings
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。